A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy (NCT02605785)

🧪 Interventions in This Study

• F-18 AV 1451 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mayo Clinic — Rochester, Minnesota

📞 Contact the Study Coordinator

Phone: (507) 284-3863

Email: boland.sarah@mayo.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Progressive Supranuclear Palsy

• Art Therapy in Progressive Supranuclear Palsy — Nashville, Tennessee
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — Carlsbad, California
• Remote Monitoring in Progressive Supranuclear Palsy (PSP) — Baltimore, Maryland
• tDCS as Treatment for Motor Function — Toronto, Ontario

Explore by condition: All Progressive Supranuclear Palsy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.